News & Events category:
NIHR Manchester Clinical Research Facility

People across Greater Manchester are being asked to play their part in helping vital research into new COVID-19 treatments.

The Chief Operating Officer of the NIHR  Clinical Research Network (CRN) Greater Manchester has volunteered to take part in a COVID-19 booster vaccine study.

The exceptional contribution of three MFT colleagues to research and innovation has been recognised by the Manchester Academic Health Science Centre (MAHSC).

A young lupus patient is encouraging others to take part in research, after she volunteered for the NIHR Immune-Mediated Inflammatory Diseases (IMID) BioResource.

For nine-year-old Leo, and his mum, Lisa, taking part in a clinical trial at the NIHR Manchester Clinical Research Facility has been important for many reasons.

Patients at Manchester Adult Cystic Fibrosis Centre are the first in Europe to have received the life-changing drug, Kaftrio, as part of standard NHS care.

The final Manchester University NHS Foundation Trust (MFT) participant has been recruited to the SIREN research study, which is investigating whether COVID-19 antibodies protect against the virus.